PROGRAMME
=========

2.00 pm Welcome

2.15pm Presented Abstracts

3.15pm Invited Abstract: Is there a place for liver transplantation from living donors? Dr John O\'Grady, Consultant Hepatologist, Liver Unit, Kings College Hospital, London.

3.40pm Tea/Coffee

4.00pm Presented Abstracts

4.35pm Guest Lecture: Prospects for stem cell therapy in cardiac regeneration. Prof Tim O\'Brien, Director, Regenerative Medicine Institute, National University of Ireland, Galway.

5.30pm Close

Current guidelines recommend nephrology referral when eGFR \<30mls/min. To determine the implications of this guideline on our nephrology unit which serves the Southern Health and Social Services Board (SHSSB) area of Northern Ireland (population 320, 000) we identified: (i) the number of patients in this area with an eGFR of 15-29 mls/min (stage 4 CKD) (ii) the factors influencing outcomes (dialysis or death) in this group.

Laboratory tests of renal function performed in 2001 were screened to identify all patients with an eGFR of 15-29 mls/min. An electronic database identified all patients referred to our unit between June 1998 and December 2000 with stage 4 CKD. Baseline and follow--up data including eGFR, 24hr proteinuria, blood pressure and death or need for dialysis was obtained.

In 2001, 1,730 patients with stage 4 CKD were identified, of whom 176 (10.2%) were known to the nephrology service. Between June 1998 and December 2000, 95 patients were referred with CKD stage 4, of whom 25% required dialysis within 5 years. This group had a lower baseline mean eGFR (21.0 vs.24.9mls/min, p = 0.0001) and a higher mean proteinuria (2.42 vs. 0.81g/dL, p = 0.01) than those who remained dialysis-independent. 50%, 33% and 9% of patients with baseline eGFR of 15-19, 20-24 and 25-29 mls/min respectively required dialysis. Currently guidelines require nephrological referral for a large number of persons, of whom only 25% require dialysis within 5 years. Future guidelines should focus on a demonstrated decline in eGFR and level of proteinuria rather than a threshold level of eGFR.

Ischaemic heart disease (IHD) is a complex disease due to the combination of environmental and genetic factors. The MEF2A gene codes for an important protein in myocardial muscle development. In a large US family a 21bp deletion (Δ7aa) was reported to be associated with IHD with an autosomal dominant pattern of inheritance (Wang *et al*. Science, 2003). We investigated this region of the MEF2A gene using an Irish family-based study, where affected individuals had early-onset IHD.

A total of 1494 individuals from 580 families were included (800 discordant sib-pairs and 64 parent-child trios). The Δ7aa region of the MEF2A gene was investigated based on amplicon size.

The Δ7aa mutation was not detected in any individual. Coincidentally, considerable variation in the number of CAG (glutamate) and CCG (proline) residues was detected in a nearby region. However, this was not found to be associated with IHD.

The Δ7aa mutation was not detected in any individual within the study population and is unlikely to play a significant role in the development of IHD in Ireland. Using family-based tests of association the number of tri-nucleotide repeats in a nearby region of the MEF2A gene was not associated with IHD in our study group.

There is increasing awareness of the importance of cardiovascular risk control in rheumatoid disease, and more recently speculation that osteoporosis may also carry an increased risk of atherosclerotic disease.

We performed a comprehensive risk analysis on 100 rheumatoid arthritis (RA) patients (20 male, 80 female, median age 60.0 years 95%CI 57.0-62.0) and 30 primary osteoporosis patients (3 male, 27 female, median age 67.5 years, 95%CI 62.8-70.0) in the outpatient setting. 8% of RA patients had a personal history of MI or stroke, compared with none of the osteoporosis cohort, although only 62% of RA had a BP check in the last year, and 28% a fasting cholesterol check, compared with 83% and 47% in osteoporosis patients.

17% of both RA and osteoporosis patients had systolic BP \>160mmHg, and 17% and 18% respectively diastolic BP \>90mmHg. There was an interesting correlation between diastolic BP and low trauma fracture in the osteoporotic patients (r = 0.56, p\<0.01), and between diastolic BP and BMI in RA patients (r = 0.37, p\<0.01). HDL:cholesterol ratio correlated with BMD at spine in the osteoporosis group (r = 0.51, p = 0.01). 57% of osteoporosis patients, and 54% of RA patients had fasting cholesterol levels \>5.2. 4 RA patients and none of the osteoporosis patients were taking lipid-lowering drugs.

**Conclusion:** Levels of cardiovascular risk were similar in both RA, a disease with known accelerated atherosclerosis, and osteoporosis, although monitoring appeared better in the osteoporosis group. Despite this, a substantial unmet need remains. A possible correlation between cardiovascular risk factors and bone health requires further investigation.

The long-term impact of dietary carbohydrate, in particular sucrose, on insulin resistance and the development of diabetes and atherosclerosis is not established. Current guidelines advise restriction of sucrose intake to 10% of total energy intake.

We investigated the effect of a high versus low sucrose diet (25% versus 10% of total energy intake). Thirteen healthy male volunteers, aged 34 ± 3 years (mean ± SEM), BMI 26.7 ± 0.9kg/m2 were included in a randomised crossover design with sequential 6-week dietary interventions separated by 4-week wash-out.

Weight maintenance diets with constant macronutrient profiles and fibre content were designed. Subjects were monitored and all food was weighed and distributed 3-5 times weekly. Insulin action was assessed using a 2-step euglycaemic clamp and the isotope dilution method (3-3H glucose) was used to determine glucose utilisation and endogenous glucose production rates.

There was no change in weight or physical activity during the study period. Suppression of endogenous glucose production was similar after each diet. At an insulin infusion rate of 2mU/kg/min, the peripheral glucose utilisation after 25% sucrose diet was 57.0 ± 4.9 mmol/kg/min compared to 47.6 ± 3.6 mmol/kg/min after a 10% sucrose diet, p=NS.

In this study, a high-sucrose intake as part of a eucaloric, weight-maintaining diet had no detrimental effect on insulin sensitivity in healthy non-diabetic subjects. These results suggest that than carbohydrate quality may be a less important determinant of insulin action than caloric excess, physical activity or weight gain.

A 63 year old female was admitted with a three month history of increasing lethargy, anorexia, diarrhoea, weight loss, depression and confusion. Past medical history included hypertension, cerebrovascular disease, heavy smoking and alcohol abuse. On clinical examination she was dehydrated, malnourished and disorientated. Initial laboratory investigations demonstrated anemia and thrombocytopenia. A profound hypokalemic hypochloremic metabolic alkalosis was present. Proteinuria was noted. Chest radiograph was normal. Electrocardiography demonstrated a prolonged corrected QT interval. Treatment with empirical intravenous antibiotics, electrolyte replacement, red cell and platelet transfusion was instituted. Computed tomography of brain, cardiac and abdominal ultrasonography were initially normal. On the sixth day following admission the patient developed fluid overload with type I respiratory failure and radiographical evidence of pulmonary oedema. She was transferred for intensive care and required intravenous antibiotics, diuretics, non-invasive ventilation and inotropic support.

On the tenth day the patient deteriorated acutely. Repeat electrocardiography revealed ST-elevation consistent with acute inferoposterolateral myocardial infarction. Echocardiography demonstrated corresponding wall motion abnormalities. Emergency coronary angiography revealed no causative atherosclerotic, thrombotic, embolic or vasospastic lesion. Left ventriculography showed inferoposterolateral akinesia in keeping with Takotsubo cardiomyopathy.

Takotsubo cardiomyopathy is a recently recognised cause of acute reversible left ventricular systolic dysfunction. The condition typically affects elderly females and presents with clinical and electrocardiographic features mimicking acute myocardial infarction. A characteristic ventricular wall motion abnormality (apical ballooning) is observed. The condition is often associated with acute physical or psychological stress and may result from catecholamine excess. Patients surviving the acute phase tend to recover spontaneously.

Type 1 diabetes in drivers of motor vehicles is assumed to be a hazard for road safety. Identification of particular risk factors may enable preventive strategies. We performed a case referent study to identify factors linked to road traffic incidents in drivers with type 1 diabetes.

An initial postal questionnaire was sent to a population of 942 patients with type 1 diabetes mellitus attending the Diabetes clinic at the Royal Victoria Hospital, Belfast. Four hundred and eighty two responders included 311 eligible participants and 171 who were ineligible. Structured telephone interviews were undertaken with the 311, identifying 92 cases (who had a road traffic incident in the past 2 years) and 219 referents.

Following multivariate analysis, risk factors for road traffic incidents were the absence of awareness of hypoglycaemic symptoms (OR 44.2, p\<0.001), the presence of only neuroglycopaenic symptoms of hypoglycaemia (OR 7.4, p\<0.01), higher insulin dose (OR 5.3, p\<0.01), a frequency of driving 5+ times per day (OR 5.6, p\<0.001), a history of having a previous hypoglycaemic episode while driving without taking sugar (OR 22.6, p\<0.01) and being on a Beta Blocker (OR 6.1, p\<0.01). Higher HbA1C level was protective (OR 0.3, p\<0.001), as was testing blood sugar before driving (OR 0.2, p\<0.001).

In conclusion the results demonstrate that intensive blood glucose management, hypoglycaemia unawareness and frequent driving are risk factors for road traffic incidents. Patients, clinicians and occupational physicians should be aware of these risk factors and of the protective value of self blood glucose monitoring before driving.

N-terminal-pro-BNP (NT-pro-BNP) is a proven diagnostic marker of congestive heart failure and predictor of recurrent ischaemic events and mortality in both stable and unstable ischaemic heart disease (IHD).[@b1],[@b2]

We hypothesized that NT-pro-BNP may be a useful diagnostic marker for IHD in patients presenting with previously undiagnosed chest pain to a rapid access chest pain clinic. NT-pro-BNP was compared as a diagnostic marker to standard risk stratification methods combined with exercise stress testing. Positive diagnosis ranged from acute coronary syndrome to possible IHD requiring further investigation.

447 consecutive patients were studied. NT-pro-BNP was significantly higher among those diagnosed with IHD versus non-IHD (95ng/L \[interquartile range 44 to 199\] vs 43ng/L \[interquartile range 22 to 72\] p = 0.029). Patients in the highest NT-pro-BNP quartile were older, had lower creatinine clearance and more cardiovascular risk factors than those in the lowest quartile. Those in the highest quartile were statistically significantly more likely to have a positive exercise stress test (EST) (p\<0.001).

Following logistic regression analysis, NT-pro-BNP in the highest quartile was predictive of a diagnosis of IHD, independent of standard risk factor profile and biochemical markers including creatinine clearance and troponin I (p = 0.001). After inclusion of EST result in the regression model, no NT-pro-BNP quartile was a significant predictor of IHD (p = 0.988).

In the setting of a rapid access chest pain clinic, NT-pro-BNP quartile does not improve IHD diagnosis more than an EST. It may be a useful prognostic indicator of morbidity and mortality in this group, and follow up data will be useful.
